Breast CA |
miR-1910-3p |
Breast CA cells |
NF-κB and wnt/β-catenin
|
↑Tumor cell growth |
[39] |
Breast CA |
miR-181D-5p |
Breast CA cells |
CDX2 and HOXA5
|
↑EMT |
[40] |
Breast CA |
miR-4516 |
Breast CA cells |
FOSL1-dependent TNBC |
↑proliferation and malignancy |
[41] |
Breast CA |
miR-3613-3p |
Breast CA cells |
Targeting the expression of SOCS2
|
↓proliferation and metastasis |
[42] |
Breast CA |
miR-27a-3p |
γδT1 cells |
Up-regulating PD-L1 through the MAGI2/PTEN/PI3K
|
↑immune escape |
[86] |
Breast CA |
miR-221-3p |
Breast CA cells |
Targeting PIK3R1 through the PI3K/AKT
|
↑resistance |
[109] |
Breast CA |
miR-155 |
Breast CA cells |
N/A |
↑resistance |
[110] |
Ovarian CA |
miR-221-3p |
Ovarian CA cells |
Inhibiting CDKN1B
|
↑progression and ↓prognosis |
[48] |
Ovarian CA |
miR-141-3p |
Endothelial cells |
Raising VEGFR-2 expression |
↑migration and angiogenesis |
[49] |
Ovarian CA |
miR-205 |
Endothelial cells |
PTEN-AKT
|
↑angiogenesis and metastasis |
[50] |
Ovarian CA |
miR21 |
Ovarian CA cells |
Combinng with APAF1
|
↓apoptosis |
[51] |
Ovarian CA |
miR-29a-3p and miR-21-5 |
CD4+ T cells |
Suppressing STAT3 and regulating Treg/Th17 cells |
↑progression and metastasis |
[94] |
Ovarian CA |
miR-21-3p, miR-21-5p and miR-891-5p |
Ovarian CA cells |
Upregulating detoxification metabolic pathways and DNA repair mechanisms |
↑resistance |
[112] |
Ovarian CA |
miR-223 |
Hypoxic macrophages |
PTEN-PI3K/AKT
|
↑resistance |
[114] |
Ovarian CA |
miR-1246 |
Ovarian CA cells |
Targeting Cav1
|
↑resistance |
[117] |
Ovarian CA |
miR-98-5p |
Ovarian CA cells |
Inhibiting CDKN1A expression |
↑resistance |
[118] |
Ovarian CA |
miR-199a-3p |
Ovarian CA cells |
Inhibiting the expression of C-Met
|
↓proliferation and invasion |
[125] |
Cervical CA |
miR-221-3p |
Endothelial cells |
Regulating MAPK10
|
↑proliferation, invasion, migration and angiogenesis |
[53] |
Cervical CA |
miR-221-3p |
Endothelial cells |
Down-regulating THBS2
|
↑angiogenesis |
[54] |
Cervical CA |
miR-155-5p |
Cervical CA cells |
Secreting pro-inflammatory cytokines (including IL-6 and IL-8) |
↑malignancy |
[55] |
Endometrial CA |
miR-133a |
Endometrial CA cells |
Down-regulating FOXL2
|
↑progression |
[57] |
Endometrial CA |
miR-148b |
Endometrial CA cells |
Binding to its downstream target gene DNMT1
|
↓metastasis |
[59] |
Endometrial CA |
miR-320a |
Endometrial CA cells |
Down-regulating HIF1 by miR-320a, leading to decreased expression of VEGFA
|
↓proliferation |
[128] |